Insider and congress filings
Moderna, Inc. (MRNA)
About Moderna, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Stéphane Bancel
- Employees
- 4,700
- Listed since
- Dec 7, 2018
- Market value
- $53.8B
- Price to earnings
- -
- Earnings per share
- -$7.96
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 31, 2026 | -$1.97 | -$2.03 | $145.0M | $102.9M | EPS beatRevenue beat |
| Q1 FY2026reported May 1, 2026 | -$3.40 | -$4.45 | $389.0M | $236.4M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 13, 2026 | -$2.11 | -$2.54 | $678.0M | $635.2M | EPS beatRevenue beat |
| Q3 FY2025reported Nov 6, 2025 | -$0.51 | -$1.87 | $1.0B | $920.9M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 1, 2025 | -$2.13 | -$2.99 | $142.0M | $893.3M | EPS beatRevenue miss |
| Q1 FY2025reported May 1, 2025 | -$2.52 | -$2.92 | $107.0M | $116.7M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 16, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Stéphane BancelChief Executive Officer | $1.7M | $6.9M | $11.4M | $19.9M |
| Stephen Hoge, M.D.President | $1.3M | $9.2M | $7.6M | $18.1M |
| James MockChief Financial Officer | $852K | $2.5M | $2.6M | $5.9M |
| Shannon Thyme KlingerChief Legal Officer and Corporate Secretary | $852K | $2.1M | $2.4M | $5.4M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| FMR LLC | $3.6B | 51,859,891 | +13.5% | 13.10% |
| Blackrock, Inc. | $2.1B | 30,599,409 | +3.3% | 7.73% |
| Vanguard Capital Management LLC | $1.6B | 23,208,792 | +1.5% | 5.86% |
| Capital World Investors | $1.6B | 22,276,996 | +19.1% | 5.63% |
| Baillie Gifford & Co | $1.3B | 18,206,778 | -8.9% | 4.60% |
| State Street Corp | $1.1B | 15,726,193 | +5.8% | 3.97% |
| Vanguard Portfolio Management LLC | $1.1B | 15,581,313 | -0.2% | 3.93% |
| Geode Capital Management, LLC | $678.8M | 9,710,335 | +2.9% | 2.45% |
| Morgan Stanley | $668.0M | 9,538,094 | +12.6% | 2.41% |
| Theleme Partners LLP | $564.3M | 8,057,571 | +0.1% | 2.03% |
| Two Sigma Investments, LP | $503.8M | 7,193,530 | -20.8% | 1.82% |
| Invesco Ltd. | $404.8M | 5,780,299 | +20.8% | 1.46% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
2 filings of 25 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Stephane BancelChief Executive Officer | Sold · 4 lines | 499,246 | $57.52 | $28.7M | Aug 5, 2026 | 2d |
| Stephen HogePresident | Sold | 53,336 | $67.60 | $3.6M | Jul 15, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in MRNA
20 disclosures of 54 on record · median 25d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -2.4%S&P -0.1% · vs S&P 500 -2.2% | Aug 24, 2026 | Sep 4, 2026 | 11d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +93.7%S&P +2.1% · vs S&P 500 +91.6% | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +198.9%S&P +5.8% · vs S&P 500 +193.1% | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +176.5%S&P +3.2% · vs S&P 500 +173.4% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +167.6%S&P +11.1% · vs S&P 500 +156.5% | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +178.4%S&P +10.6% · vs S&P 500 +167.8% | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +448.4%S&P +18.2% · vs S&P 500 +430.2% | Aug 26, 2025 | Sep 9, 2025 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +297.1%S&P +19.7% · vs S&P 500 +277.4% | Jul 25, 2025 | Aug 7, 2025 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +413.9%S&P +28.2% · vs S&P 500 +385.7% | May 19, 2025 | Jun 10, 2025 | 22d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +453.5%S&P +45.4% · vs S&P 500 +408.1% | Apr 10, 2025 | May 12, 2025 | 32d |
| Robert Bresnahan | Stock | Sale | $1,001 - $15,000 | +450.4%S&P +53.5% · vs S&P 500 +396.9% | Apr 8, 2025 | May 8, 2025 | 30d |
| Robert Bresnahan | Stock | Purchase | $1,001 - $15,000 | +307.5%S&P +28.3% · vs S&P 500 +279.2% | Feb 25, 2025 | Mar 27, 2025 | 30d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +277.7%S&P +24.3% · vs S&P 500 +253.4% | Feb 19, 2025 | Mar 6, 2025 | 15d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +307.5%S&P +28.3% · vs S&P 500 +279.2% | Feb 25, 2025 | Mar 6, 2025 | 9d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +290.0%S&P +28.6% · vs S&P 500 +261.4% | Jan 15, 2025 | Feb 12, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +134.9%S&P +30.5% · vs S&P 500 +104.4% | Oct 14, 2024 | Nov 8, 2024 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +56.6%S&P +43.1% · vs S&P 500 +13.6% | Aug 2, 2024 | Sep 6, 2024 | 35d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +25.7%S&P +50.8% · vs S&P 500 -25.1% | Apr 23, 2024 | May 6, 2024 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +31.6%S&P +46.1% · vs S&P 500 -14.5% | Mar 20, 2024 | Apr 5, 2024 | 16d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +37.0%S&P +55.9% · vs S&P 500 -18.9% | Feb 1, 2024 | Mar 7, 2024 | 35d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
1 member · estimate, as of Sep 10, 20261 member reports a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Jasmine Crockett | Democrat · House | $15,001 - $50,000 | 64.6% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (12)
| Insider | Event | Shares | Date |
|---|---|---|---|
| James M. MockChief Financial Officer | Tax withholding | 5,704 | Sep 4, 2026 |
| James M. MockChief Financial Officer | Option exercise | 11,797 | Sep 4, 2026 |
| Shannon Thyme KlingerChief Legal Officer | Option exercise | 11,797 | Sep 4, 2026 |
| Shannon Thyme KlingerChief Legal Officer | Tax withholding | 5,704 | Sep 4, 2026 |
| Stephane BancelChief Executive Officer | Option exercise | 317,397 | Aug 6, 2026 |
| Stephane BancelChief Executive Officer | Option exercise | 998,492 | Aug 5, 2026 |
| Stephen HogePresident | Option exercise | 53,336 | Jul 15, 2026 |
| Michael R. McDonnellDirector | Stock award | 14,766 | Jul 8, 2026 |
| Soria Ester BanqueChief Commercial Officer | Stock award | 57,022 | Jul 5, 2026 |
| James M. MockChief Financial Officer | Tax withholding | 703 | Jul 2, 2026 |
| James M. MockChief Financial Officer | Option exercise | 1,452 | Jul 2, 2026 |
| Stephen HogePresident | Option exercise | 53,336 | Jun 15, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling MRNA?
Across the 2 most recent open-market filings shown here, 0 were purchases and 2 were sales.
Which members of Congress have traded MRNA?
Ro Khanna, Robert Bresnahan, Julie Johnson, Josh Gottheimer disclosed MRNA transactions in the filings shown here.
Which members of Congress hold MRNA?
1 member of Congress reports a position in MRNA in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Jasmine Crockett. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is MRNA in the S&P 500 or the Nasdaq 100?
Moderna, Inc. is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are MRNA trades disclosed?
Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.